Focusing on the research, development and commercialization
of innovative agents for schizophrenia
ZHONGZE Therapeutics is a clinical stage company committed to discovering innovative medicines that will contribute to a world without suffering from schizophrenia.
R&D
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers
Room 1101, 781 Cailun Road, Pudong New District, Shanghai, China (R&D Center)
+86(21) 58787077
bd@zhongzetherapeutics.com
